Izabela P. Klaska
London, ENG SE19RT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Targeted delivery of autoantigen to dendritic cells prevents development of spontaneous uveitis.
Journal: Frontiers in immunology
Published: May 23, 2023
Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization.
Journal: Experimental eye research
Published: October 18, 2021
Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.
Journal: Molecular pharmaceutics
Published: May 22, 2020
Low-dose 2-deoxy glucose stabilises tolerogenic dendritic cells and generates potent in vivo immunosuppressive effects.
Journal: Cellular and molecular life sciences : CMLS
Published: April 09, 2020
Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Journal: Frontiers in immunology
Published: February 14, 2020
Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease.
Neonatal brain-directed gene therapy rescues a mouse model of neurodegenerative CLN6 Batten disease.
Journal: Human molecular genetics
Published: June 12, 2019
Stabilization of myeloid-derived HIFs promotes vascular regeneration in retinal ischemia.
Journal: Angiogenesis
Published: March 07, 2019
Partial retinal photoreceptor loss in a transgenic mouse model associated with reduced levels of interphotoreceptor retinol binding protein (IRBP, RBP3).
Journal: Experimental eye research
Published: July 12, 2017
The critical points in induction of experimental autoimmune uveitis.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Published: May 16, 2015
Mouse models of autoimmune uveitis.
Journal: Current pharmaceutical design
Published: January 27, 2015
Last Updated: 09/26/2026